Alaska Admin. Code tit. 12, § 52.620
Wholesale drug facilities
Effective Dec 28, 2022Alaska Register 244(Eff. 1/16/98, Register 145; am 10/31/2019, Register 232; am 12/28/2022, Register 244) | Authority: AS 08.80.005, AS 08.80.157, AS 08.80.480, AS 08.80.030, AS 08.80.159
(a) A wholesale drug facility in which drugs or devices are stored, repacked, or sold to persons, businesses, or government agencies that may legally purchase drugs or devices must
- (1) have storage areas that ensure proper lighting, ventilation, temperature, sanitation, humidity, space, equipment, and security conditions;
- (2) be of suitable size, construction, and location to facilitate cleaning, maintenance, and proper operations;
- (3) be equipped with an alarm system to detect entry into the wholesale drug facility after business hours;
- (4) meet all applicable federal, state, and local building standards;
- (5) be secure from unauthorized entry from outside the facility, including having exterior lighting along the outside perimeter of the facility;
- (6) restrict entry into areas inside the facility where drugs or devices are stored; entry must be open to authorized personnel only;
- (7) have a quarantine area for storage of drugs or devices that are outdated, damaged, deteriorated, misbranded, or adulterated, or that are in a secondary container that has been opened or the seal of which has been broken;
- (8) be maintained in a clean and orderly condition; and
- (9) be free from infestation by insects, rodents, birds, or vermin of any kind.
- (b) A wholesale drug facility must develop internal security policies, including protection of computer records, to provide reasonable protection against theft or diversion of drugs by personnel.
- (c) A wholesale drug facility may not be located in a residence.
- (d) A wholesale drug distributor facility seeking to ship into or distribute prescription drugs or devices in this state must first verify that the purchaser of the prescription drugs or devices holds a valid license under AS 08 to supply the drug or device as described in AS 08.80.400 within the scope of the purchaser's practice
(Eff. 1/16/98, Register 145; am 10/31/2019, Register 232; am 12/28/2022, Register 244)
Authority: AS 08.80.005, AS 08.80.157, AS 08.80.480, AS 08.80.030, AS 08.80.159